Stock data
Boundless Bio, Inc. (BOLD)
Boundless Bio, Inc. (BOLD) reported net income of -US$58.20M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | -US$63.55M | -US$58.20M | — |
| 2024 | — | — | -US$73.27M | -US$65.36M | — |
| 2023 | — | — | -US$54.80M | -US$49.43M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | — | -US$23.69M | — |
| 2026-03-31 | — | -US$13.55M | — |
| 2025-12-31 | — | -US$12.88M | — |
| 2025-09-30 | — | -US$13.88M | — |
| 2025-06-30 | — | -US$15.68M | — |
| 2025-03-31 | — | -US$15.76M | — |
| 2024-12-31 | — | -US$16.45M | — |
| 2024-09-30 | — | -US$16.51M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.